BEACON MEDICAL GROUP
PLYMPTON HEALTH CENTRE, MUDGE WAY, PLYMPTON, PLYMOUTH
HF 4
The percentage of patients with a current diagnosis of heart failure due to LVD who are currently treated with an ACE inhibitor or Angiotensin Receptor Blocker, who are additionally treated with a beta-blocker licensed for heart failure, or recorded as intolerant to or having a contraindication to beta-blockers.
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| HF 4 | 2010 | 12 | 15 | 80.0% | |
| HF 4 | 2011 | 13 | 16 | 81.2% | |
| HF 4 | 2012 | 12 | 18 | 66.7% | |
| HF 4 | 2013 | 18 | 23 | 78.3% | |
| HF004 | 2014 | 8 | 8 | 100.0% | |
| HF004 | 2015 | 27 | 28 | 96.4% | |
| HF004 | 2016 | 49 | 51 | 96.1% | |
| HF004 | 2017 | 47 | 48 | 97.9% | |
| HF004 | 2018 | 59 | 66 | 89.4% | |
| HF004 | 2019 | 62 | 73 | 84.9% | |
| HF004 | 2020 | 97 | 110 | 88.2% | |
| HF006 | 2021 | 115 | 140 | 82.1% | |
| HF006 | 2022 | 127 | 133 | 95.5% | |
| HF006 | 2023 | 220 | 236 | 93.2% |
